Thomas Gad, See remarks at Y-mAbs Therapeutics, Inc. (YMAB), sold 176,110 shares at $10.96 ($1.9M) on 2022-01-24, disclosed to the SEC on 2022-01-26.
Open-market sale of $1.9M YMAB by See remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.07 | 32,272 | $325K | 17.4% |
| 2 | $10.07 | 32,272 | $325K | 17.4% |
| 3 | $10.96 | 55,783 | $611K | 32.6% |
| 4 | $10.96 | 55,783 | $611K | 32.6% |
| Total | $10.63 avg | 176,110 | $1.9M | 100% |
| Filing → |
| YMAB | SELL | 2024-06-11 | $841K | — | Filing → |
| YMAB | SELL | 2024-05-23 | $396K | — | Filing → |
| YMAB | SELL | 2024-03-07 | $128K | — | Filing → |